In a single study of 154 patients with ALT levels greater than 5 × ULN without jaundice or coagulopathy, comparing with untreated controls (n = 52), LAM (n = 102) showed no beneficial effects regarding the protection from progressing to hepatic decompensation. The gene discussed is GPT; the disease is Jaundice.